Gates Foundation donates $150 million to push coronavirus vaccine doses below $3

Bill and Melinda Gates.
(Image credit: Getty Images/Getty Images for Global Citizen)

The Bill & Melinda Gates Foundation is trying to make sure an eventual coronavirus vaccine is affordable for everyone.

The foundation has donated $150 million to the Serum Institute of India, the world's largest vaccine maker, the Gavi vaccine alliance announced Friday. The money will help speed up the development and distribution of an eventual COVID-19 vaccine and make it available to 92 poorer countries for no more than $3 per dose.

"Too many times we've seen the most vulnerable countries left at the back of the queue when it comes to new treatments, new diagnostics and new vaccines," said Gavi CEO Dr. Seth Berkley. But the consequences of such inequities when distributing a COVID-19 vaccine would be devastating. "If only the wealthiest countries in the world are protected, then international trade, commerce and society as a whole will continue to be hit hard as the pandemic continues to rage across the globe," Berkley continued.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

The Serum Institute of India is one of several manufacturers working with AstraZeneca to make its candidate vaccine. It's also the go-to supplier for the World Health Organization, The Wall Street Journal notes. A total of 92 countries will be eligible to receive the discount vaccine as Gavi seeks $2 billion total to further support vaccine access.

Continue reading for free

We hope you're enjoying The Week's refreshingly open-minded journalism.

Subscribed to The Week? Register your account with the same email as your subscription.